Abstract:Prostate cancer (PCa) testing is currently based on measurement of serum prostate-specific antigen levels and digital rectal examination, which are limited by a low predictive value and the adverse effects associated with overdiagnosis and overtreatment. Recent studies have reported that the abnormal expression of microRNAs (miRNAs) is associated with the mechanism underlying the development of PCa. Thus, the aim of the present study was to investigate the effects of miR-30e and its target gene, M3 muscarinic acetylcholine receptor (CHRM3), on the adhesion, migration, invasion and cell cycle distribution of PCa cells via the mitogen-activated protein kinase (MAPK) signaling pathway. The differentially expressed genes were screened in the Gene Expression Omnibus database from a gene expression microarray (GSE55945) of PCa. PCa tissues and adjacent tissues were collected from patients with PCa. The PC-3 and DU145 human PCa cell lines were treated with activator, inhibitor and siRNAs. The effects of miR-30e on cell adhesion, migration, invasion and cell cycle distribution with the involvement of CHRM3 and the MAPK signaling pathway were investigated. The bioinformatics results demonstrated that the CHRM3 gene and the MAKP signaling pathway were involved in the progression of PCa, and has-miR-30e was selected for further study. The levels of miR-30e were significantly downregulated, while the levels of CHRM3 were obviously upregulated in PCa. CHRM3 was verified as a target gene of miR-30e. Upregulation of miR-30e and downregulation of CHRM3 decreased the levels of p-P38, p-extracellular signal-regulated kinase, p-c-Jun N-terminal kinase, p-c-fos and p-c-JUN, cell adhesion, migration and invasion ability, and the number of cells in the S phase, while they increased the number of cells in the G0 and G1 phases. The findings of the present study suggest that miR-30e inhibited the adhesion, migration, invasion and cell cycle entry of PCa cells by suppressing the activation of the MAPK signaling pathway and inhibiting CHRM3 expression. Thus, miR-30e may serve as a candidate target for the treatment of PCa.

Inhibition of microRNA-300 inhibits cell adhesion, migration, and invasion of prostate cancer cells by promoting the expression of DAB1

Nonconserved Mir‐608 Suppresses Prostate Cancer Progression Through RAC2/PAK4/LIMK1 and BCL2L1/caspase‐3 Pathways by Targeting the 3′‐utrs of RAC2/BCL2L1 and the Coding Region of PAK4

Androgen receptor-regulated miRNA-193a-3p targets AJUBA to promote prostate cancer cell migration.

MiR-199a-3p Suppresses Proliferation and Invasion of Prostate Cancer Cells by Targeting Smad1

MicroRNA-30e Inhibits Adhesion, Migration, Invasion and Cell Cycle Progression of Prostate Cancer Cells Via Inhibition of the Activation of the MAPK Signaling Pathway by Downregulating CHRM3

miR-200b suppresses cell proliferation, migration and enhances chemosensitivity in prostate cancer by regulating Bmi-1.

[Effects of Mir-145 on the Migration and Invasion of Prostate Cancer PC3 Cells by Targeting DAB2].

MicroRNA-218 Inhibits the Migration, Epithelial-Mesenchymal Transition and Cancer Stem Cell Properties of Prostate Cancer Cells.

Microrna-330 Inhibits Cell Motility By Downregulating Sp1 In Prostate Cancer Cells

miR-593-3p Promotes Proliferation and Invasion in Prostate Cancer Cells by Targeting ADIPOR1

MicroRNA-501-5p Targets PINX1 Gene to Regulate the Proliferation, Migration, and Invasion of Prostatic Carcinoma Cells

MIR-300 in the Imprinted DLK1-DIO3 Domain Suppresses the Migration of Bladder Cancer by Regulating the SP1/MMP9 Pathway

Effect of the Circcdr1as/mir-641/Xiap Regulatory Axis on the Proliferation and Invasion of the Prostate Cancer PC-3 Cell Line

microRNA-183-3p Inhibits Progression of Human Prostate Cancer by Downregulating High-Mobility Group Nucleosome Binding Domain 5.

MicroRNA-194 Regulates Cell Viability and Apoptosis by Targeting CDH2 in Prostatic Cancer

Effects of miR-200c on the migration and invasion abilities of human prostate cancer Du145 cells and the corresponding mechanism

MiR-573 Inhibits Prostate Cancer Metastasis by Regulating Epithelial-Mesenchymal Transition.

MiR-203 over-expression promotes prostate cancer cell apoptosis and reduces ADM resistance

Mir-601 Inhibits Proliferation, Migration and Invasion of Prostate Cancer Stem Cells by Targeting KRT5 to Inactivate the Wnt Signaling Pathway.

MicroRNA-143 Inhibits Cell Migration and Invasion by Targeting Matrix Metalloproteinase 13 in Prostate Cancer.

MiR-206 inhibits proliferation and migration of prostate cancer cells by targeting CXCL11.